181 related articles for article (PubMed ID: 19522026)
1. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo.
van Geer MA; Bakker CT; Koizumi N; Mizuguchi H; Wesseling JG; Oude Elferink RP; Bosma PJ
World J Gastroenterol; 2009 Jun; 15(22):2754-62. PubMed ID: 19522026
[TBL] [Abstract][Full Text] [Related]
2. A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.
Van Geer MA; Brevoord D; Kuhlmann KF; Bakker CT; Mizuguchi H; Wesseling JG; Ten Kate FJ; Gouma DJ; Oude Elferink RP; Bosma PJ
Int J Oncol; 2010 Jan; 36(1):233-44. PubMed ID: 19956852
[TBL] [Abstract][Full Text] [Related]
3. Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.
Behr M; Kaufmann JK; Ketzer P; Engelhardt S; Mück-Häusl M; Okun PM; Petersen G; Neipel F; Hassel JC; Ehrhardt A; Enk AH; Nettelbeck DM
PLoS One; 2014; 9(4):e95723. PubMed ID: 24760010
[TBL] [Abstract][Full Text] [Related]
4. Peptide targeting of adenoviral vectors to augment tumor gene transfer.
Ballard EN; Trinh VT; Hogg RT; Gerard RD
Cancer Gene Ther; 2012 Jul; 19(7):476-88. PubMed ID: 22595794
[TBL] [Abstract][Full Text] [Related]
5. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
[TBL] [Abstract][Full Text] [Related]
6. Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.
Lucas T; Benihoud K; Vigant F; Schmidt CQ; Wortmann A; Bachem MG; Simmet T; Kochanek S
PLoS One; 2015; 10(2):e0117254. PubMed ID: 25692292
[TBL] [Abstract][Full Text] [Related]
7. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
8. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
[TBL] [Abstract][Full Text] [Related]
9. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
Man YKS; Davies JA; Coughlan L; Pantelidou C; Blázquez-Moreno A; Marshall JF; Parker AL; Halldén G
Mol Cancer Ther; 2018 Feb; 17(2):575-587. PubMed ID: 29367266
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
[TBL] [Abstract][Full Text] [Related]
11. Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
Miura Y; Yoshida K; Nishimoto T; Hatanaka K; Ohnami S; Asaka M; Douglas JT; Curiel DT; Yoshida T; Aoki K
Gene Ther; 2007 Oct; 14(20):1448-60. PubMed ID: 17700705
[TBL] [Abstract][Full Text] [Related]
12. Ablating CAR and integrin binding in adenovirus vectors reduces nontarget organ transduction and permits sustained bloodstream persistence following intraperitoneal administration.
Akiyama M; Thorne S; Kirn D; Roelvink PW; Einfeld DA; King CR; Wickham TJ
Mol Ther; 2004 Feb; 9(2):218-30. PubMed ID: 14759806
[TBL] [Abstract][Full Text] [Related]
13. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
14. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
[TBL] [Abstract][Full Text] [Related]
15. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
Rittner K; Schreiber V; Erbs P; Lusky M
Cancer Gene Ther; 2007 May; 14(5):509-18. PubMed ID: 17318198
[TBL] [Abstract][Full Text] [Related]
16. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
17. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.
Kim J; Smith T; Idamakanti N; Mulgrew K; Kaloss M; Kylefjord H; Ryan PC; Kaleko M; Stevenson SC
J Virol; 2002 Feb; 76(4):1892-903. PubMed ID: 11799184
[TBL] [Abstract][Full Text] [Related]
18. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.
Kraaij R; van Rijswijk AL; Oomen MH; Haisma HJ; Bangma CH
Prostate; 2005 Feb; 62(3):253-9. PubMed ID: 15389777
[TBL] [Abstract][Full Text] [Related]
20. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.
Smith T; Idamakanti N; Kylefjord H; Rollence M; King L; Kaloss M; Kaleko M; Stevenson SC
Mol Ther; 2002 Jun; 5(6):770-9. PubMed ID: 12027562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
